Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, sex steroids, osteocalcin and bone mineral density in male and female rats

被引:8
|
作者
Fukuda, R [1 ]
Usuki, S [1 ]
Mukai, N [1 ]
Amagai, H [1 ]
Hayashi, K [1 ]
Takamatsu, K [1 ]
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan
关键词
IGF-I; IGFBP-3; testosterone; 17; beta-estradiol; osteocalcin; bone mineral density; sexual maturation; aging; rat;
D O I
10.3109/09513599809012830
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although it has been reported that the race of weight gain and linear growth increases markedly during puberty in rats, little is Known about the relationship between endocrine changes and bone mineral density (BMD) changes upon sexual maturation in these animals. The aim of this study was to examine the levels of serum insulin-like growth factor-I (ICF-I), IGF binding protein (IGFBP)-3, sex steroids and osteocalcin, and the changes in BMD in normal aging male and female rats. Male rats exhibited increases in serum IGF-I and IGFBP-3 concentrations before increases in serum testosterone levels. IGF-land testosterone peaked at 9 weeks of age, and thereafter remained in a steady state, whereas IGFBP-3 reached a peak at 7 weeks of age, and then gradually declined. A strong correlation between serum IGF-I and IGFBP-3 levels was found in subjects 3-9 weeks old. A highly significant correlation between serum IGF-I and testosterone levels was also found. In females, serum 17 beta-estradiol, IGF-I and IGFBP-3 levels increased gradually from 3 to 5 weeks old, peaked at 9 weeks, and then decreased slowly thereafter. The correlation coefficient between serum IGF-I and IGFBP-3 was highly significant. The correlation coefficient between serum IGF-I and 17 beta-estradiol levels was weak, although it war strongest when the subjects were 3-9 weeks old. Serum osteocalcin is a marker of bone formation; its level remained relatively high from 3 to 9 and from 3 to 7 weeks of age in males and females, respectively, although osteocalcin in both sexes declined gradually with age. As for bone mass, sharp increases in BMD in. the tibia, femur and lumbar vertebrae appeared earlier in female than in male rats, and the BMD in females tended to be higher than in males between 5 and 9 weeks old. After 9 weeks of age, BMD in males was higher than that in females, as BMD in males continued to increase whereas females tended to remain in a steady state after this stage. The correlation coefficients between tibial BMD and serum IGF-I or IGFBP-3 levels were highly significant when the subjects were from 3 to 9 weeks old. Taken together, these results suggest that BMD development occurs earlier in female than in male rats. This sex-related difference in changer in the BMD pattern may result from the earlier onset of puberty in females, and from sex-specific differences in concentrations of IGF-I, IGFBP-3 and sex steroids during maturation.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 50 条
  • [1] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 in premature rupture of membranes
    Loukovaara, M
    Koistinen, R
    Kalme, T
    Kurki, T
    Leinonen, P
    Seppälä, M
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (10) : 905 - 908
  • [2] Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in obese children
    Bideci, A
    Cinaz, P
    Hasanoglu, A
    Elbeg, S
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1997, 10 (03): : 295 - 299
  • [3] Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis
    Toussirot, E
    Nguyen, NU
    Dumoulin, G
    Regnard, J
    Wendling, D
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (11): : 1172 - 1176
  • [4] Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease
    Duron, Emmanuelle
    Funalot, Benoit
    Brunel, Nadege
    Coste, Joel
    Quinquis, Laurent
    Viollet, Cecile
    Belmin, Joel
    Jouanny, Pierre
    Pasquier, Florence
    Treluyer, Jean-Marc
    Epelbaum, Jacques
    le Bouc, Yves
    Hanon, Olivier
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4673 - 4681
  • [5] Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death
    Lin, YS
    Tamakoshi, A
    Kikuchi, S
    Yagyu, K
    Obata, Y
    Ishibashi, T
    Kawamura, T
    Inaba, Y
    Kurosawa, M
    Motohashi, Y
    Ohno, Y
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (04) : 584 - 588
  • [6] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma
    Sungshim Lani Park
    Veronica Wendy Setiawan
    Peter A. Kanetsky
    Zuo-Feng Zhang
    Lynne R. Wilkens
    Laurence N. Kolonel
    Loïc Le Marchand
    [J]. Cancer Causes & Control, 2011, 22 : 1267 - 1275
  • [7] Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis.
    Toussirot, E
    Nguyen, NU
    Dumoulin, G
    Regnard, J
    Wendling, D
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S305 - S305
  • [8] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 are not useful markers of prostate cancer
    Zancan, M.
    Dittadi, R.
    Scattoni, V.
    Fandella, A.
    Del Bianco, P.
    Gion, M.
    [J]. EJC SUPPLEMENTS, 2007, 5 (08): : 36 - 36
  • [9] Serum concentrations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in patients with chronic hepatitis
    Okan, A
    Çömlekçi, A
    Akpmar, H
    Okan, I
    Yesil, S
    Tankurt, E
    Simsek, I
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (11) : 1212 - 1215
  • [10] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma
    Park, Sungshim Lani
    Setiawan, Veronica Wendy
    Kanetsky, Peter A.
    Zhang, Zuo-Feng
    Wilkens, Lynne R.
    Kolonel, Laurence N.
    Le Marchand, Loic
    [J]. CANCER CAUSES & CONTROL, 2011, 22 (09) : 1267 - 1275